REFERENCES
  1. Deferm S, Bertrand PB, Verbrugge FH, et al. Atrial functional mitral regurgitation: JACC review topic of the week. J Am Coll Cardiol. 2019;73(19):2465-2476.
  2. Chehab O, Roberts-Thomson R, Ng YLC, et al. Secondary mitral regurgitation: pathophysiology, proportionality and prognosis. Heart. 2020;106(10):716-723.
  3. Asgar AW, Mack MJ, Stone GW. Secondary mitral regurgitation in heart failure: pathophysiology, prognosis, and therapeutic considerations. J Am Coll Cardiol. 2015;65(12):1231-1248.
  4. Iung B, Vahanian A. Epidemiology of valvular heart disease in the adult. Nat Rev Cardiol. 2011;8(3):162-172.
  5. Bartko PE, Hülsmann M, Hung J, et al. Secondary valve regurgitation in patients with heart failure with preserved ejection fraction, heart failure with mid-range ejection fraction, and heart failure with reduced ejection fraction [published online ahead of print, 2020 Apr 29]. Eur Heart J. 2020;ehaa129.
  6. Dziadzko V, Clavel MA, Dziadzko M, et al. Outcome and undertreatment of mitral regurgitation: a community cohort study. Lancet. 2018;391(10124):960-969.
  7. Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38(36):2739-2791
  8. Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. J Am Coll Cardiol. 2017;70(2):252-289.
  9. Bonow RO, O’Gara PT, Adams DH, et al. 2020 Focused Update of the 2017 ACC Expert Consensus Decision Pathway on the management of mitral regurgitation: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2020;75(17):2236-2270
  10. Goel SS, Bajaj N, Aggarwal B, et al. Prevalence and outcomes of unoperated patients with severe symptomatic mitral regurgitation and heart failure: comprehensive analysis to determine the potential role of MitraClip for this unmet need. J Am Coll Cardiol. 2014;63(2):185-186.
  11. Acker MA, Parides MK, Perrault LP, et al. Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med. 2014;370(1):23-32.
  12. Goldstein D, Moskowitz AJ, Gelijns AC, et al. Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation. N Engl J Med. 2016;374(4):344-353.
  13. Smith PK, Puskas JD, Ascheim DD, et al. Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med. 2014;371(23):2178-2188.
  14. Michler RE, Smith PK, Parides MK, et al. Two-year outcomes of surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med. 2016;374(20):1932-1941.
  15. Obadia JF, Messika-Zeitoun D, Leurent G, et al. Percutaneous repair or medical treatment for secondary mitral regurgitation. N Engl J Med. 2018;379(24):2297-2306.
  16. Stone GW, Lindenfeld J, Abraham WT, et al. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med. 2018;379(24):2307-2318.
  17. Wan S, Hu J. Commentary: Following the game-changers: Are we on the right track now? J Thorac Cardiovasc Surg. (in press) Doi:10.1016/j.jtcvs.2020.06.070
  18. Sannino A, Smith RL 2nd, Schiattarella GG, et al. Survival and cardiovascular outcomes of patients with secondary mitral regurgitation: a systematic review and meta-analysis. JAMA Cardiol. 2017;2(10):1130-1139.
  19. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129-2200.
  20. Nieminen MS, Brutsaert D, Dickstein K, et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J. 2006;27(22):2725-36.
  21. Díez-Villanueva P, Vera A, Ariza-Solé A, et al. Mitral regurgitation and prognosis after non-ST-segment elevation myocardial infarction in very old patients. J Am Geriatr Soc. 2019;67(8):1641-1648.
  22. Barra S, Providência R, Paiva L, et al. Mitral regurgitation during a myocardial infarction–new predictors and prognostic significance at two years of follow-up. Acute Card Care. 2012;14(1):27-33.
  23. Valuckienė Ž, Urbonaitė D, Jurkevičius R. Functional (ischemic) mitral regurgitation in acute phase of myocardial infarction: Associated clinical factors and in-hospital outcomes. Medicina (Kaunas). 2015;51(2):92-9.
  24. The Writing Committee of the Report on Cardiovascular Health and Diseases in China. Report on cardiovascular health and diseases in China 2019: an updated summary. Chinese Circulation Journal, 2020;35:833.
  25. Zhang Y, Zhang J, Butler J, et al. Contemporary epidemiology, management, and outcomes of patients hospitalized for heart failure in China: results from the China Heart Failure (China-HF) Registry. J Card Fail. 2017;23(12):868-875.
  26. Guan W, Venkatesh AK, Bai X, et al. Time to hospital arrival among patients with acute myocardial infarction in China: a report from China PEACE prospective study. Eur Heart J Qual Care Clin Outcomes. 2019;5(1):63-71.
  27. Hao G, Wang X, Chen Z, et al. Prevalence of heart failure and left ventricular dysfunction in China: the China Hypertension Survey, 2012-2015. Eur J Heart Fail. 2019;21(11):1329-1337.
  28. Mentias A, Raza MQ, Barakat AF, et al. Prognostic significance of ischemic mitral regurgitation on outcomes in acute ST-elevation myocardial infarction managed by primary percutaneous coronary intervention. Am J Cardiol. 2017;119(1):20-26.
  29. Kaneko H, Suzuki S, Uejima T, et al. Prevalence and the long-term prognosis of functional mitral regurgitation in Japanese patients with symptomatic heart failure. Heart Vessels. 2014;29(6):801-7.
  30. Naser N, Dzubur A, Kusljugic Z, et al. Echocardiographic assessment of ischaemic mitral regurgitation, mechanism, severity, impact on treatment strategy and long term outcome. Acta Inform Med. 2016;24(3):172-7.
  31. Li L, Liu R, Jiang C, et al. Assessing the evidence-practice gap for heart failure in China: the Heart Failure Registry of Patient Outcomes (HERO) study design and baseline characteristics. Eur J Heart Fail. 2020 Apr;22(4):646-660.
  32. Oliva F, Mortara A, Cacciatore G, et al. Acute heart failure patient profiles, management and in-hospital outcome: results of the Italian Registry on Heart Failure Outcome. Eur J Heart Fail. 2012;14(11):1208-17.
  33. Kajimoto K, Minami Y, Otsubo S, et al. Ischemic or nonischemic functional mitral regurgitation and outcomes in patients with acute decompensated heart failure with preserved or reduced ejection fraction. Am J Cardiol. 2017;120(5):809-816.
  34. Perez de Isla L, Zamorano J, Quezada M, et al. Prognostic significance of functional mitral regurgitation after a first non-ST-segment elevation acute coronary syndrome. Eur Heart J. 2006;27(22):2655-60.
  35. Li J, Li X, Wang Q, et al. ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data. Lancet. 2015;385(9966):441-51.
  36. Hillis GS, Møller JE, Pellikka PA, et al. Prognostic significance of echocardiographically defined mitral regurgitation early after acute myocardial infarction. Am Heart J. 2005;150(6):1268-75.
  37. Grayburn PA, Sannino A, Packer M. Proportionate and disproportionate functional mitral regurgitation: a new conceptual framework that reconciles the results of the MITRA-FR and COAPT trials. JACC Cardiovasc Imaging. 2019;12(2):353-362.
  38. Milton Packer, Paul A Grayburn. Contrasting effects of pharmacological, procedural, and surgical interventions on proportionate and disproportionate functional mitral regurgitation in chronic heart failure. Circulation. 2019;140(9):779-789.
  39. Milton Packer, Paul A Grayburn. New evidence supporting a novel conceptual framework for distinguishing proportionate and disproportionate functional mitral regurgitation. JAMA Cardiol. 2020; 5(4):469-475.
  40. Kampaktsis PN, Lebehn M, Wu IY. Mitral regurgitation in 2020: the 2020 focused update of the 2017 American College of Cardiology Expert Consensus Decision Pathway on the management of mitral regurgitation. J Cardiothorac Vasc Anesth. 2020:S1053-0770(20)30851-X.
  41. Fanaroff AC, Califf RM, Harrington RA, et al. Randomized trials versus common sense and clinical observation: JACC review topic of the week. J Am Coll Cardiol. 2020;76(5):580-589.
  42. Biner S, Rafique A, Rafii F, et al. Reproducibility of proximal isovelocity surface area, vena contracta, and regurgitant jet area for assessment of mitral regurgitation severity. JACC Cardiovasc Imaging. 2010;3(3):235-43.
  43. Shanks M, Siebelink HM, Delgado V, et al. Quantitative assessment of mitral regurgitation: comparison between three-dimensional transesophageal echocardiography and magnetic resonance imaging. Circ Cardiovasc Imaging. 2010;3(6):694-700.
  44. Feldman T, Foster E, Glower DD, et al. Percutaneous repair or surgery for mitral regurgitation [published correction appears in N Engl J Med. 2011 Jul 14;365(2):189. Glower, Donald G [corrected to Glower, Donald D]]. N Engl J Med. 2011;364(15):1395-1406.
  45. Gammie JS, Chikwe J, Badhwar V, et al. Isolated mitral valve surgery: the Society of Thoracic Surgeons Adult Cardiac Surgery Database analysis. Ann Thorac Surg. 2018;106(3):716-727.
  46. Nappi F, Antoniou GA, Nenna A, et al. Treatment options for ischemic mitral regurgitation: A meta-analysis. J Thorac Cardiovasc Surg. 2020:S0022-5223(20)31262-9.
  47. Monteagudo Ruiz JM, Zamorano Gómez JL. Importance of the left ventricle in secondary mitral regurgitation. Hunt with cats and you catch only rats. Rev Esp Cardiol (Engl Ed). 2019;72(12):994-997.
  48. Nappi F, Avtaar Singh SS, Padala M, et al. The choice of treatment in ischemic mitral regurgitation with reduced left ventricular function. Ann Thorac Surg. 2019;108(6):1901-1912.
  49. Calafiore AM, Prapas S, Abukoudair W, et al. Has moderate ischemic mitral regurgitation to be corrected?-Analysis of a randomized trial. Ann Transl Med. 2016;4(Suppl 1):S66.
  50. Taramasso M, Maisano F. Valvular disease: Functional mitral regurgitation: should all valves be replaced? Nat Rev Cardiol. 2016;13(2):65-6.
  51. Capoulade R, Zeng X, Overbey JR, et al. Impact of left ventricular to mitral valve ring mismatch on recurrent ischemic mitral regurgitation after ring annuloplasty. Circulation. 2016;134(17):1247-1256.
  52. Kron IL, Hung J, Overbey JR, et al. Predicting recurrent mitral regurgitation after mitral valve repair for severe ischemic mitral regurgitation. J Thorac Cardiovasc Surg. 2015;149(3):752-61.e1.
  53. Mihos CG, Capoulade R, Yucel E, et al. Mitral valve and subvalvular repair for secondary mitral regurgitation: rationale and clinical outcomes of the papillary muscle sling. Cardiol Rev. 2018;26(1):22-28.
  54. Wan S, Hu J, Liu J. Reply: Anatomical or functional repair for ischemic mitral regurgitation: Find the right antidote! J Thorac Cardiovasc Surg (in press) Doi:10.1016/j.jtcvs.2021.01.073
  55. Nappi F, Spadaccio C, Nenna A, et al. Is subvalvular repair worthwhile in severe ischemic mitral regurgitation? Subanalysis of the Papillary Muscle Approximation trial. J Thorac Cardiovasc Surg. 2017;153(2):286-295.e2.
  56. Szymanski C, Bel A, Cohen I, et al. Comprehensive annular and subvalvular repair of chronic ischemic mitral regurgitation improves long-term results with the least ventricular remodeling. Circulation. 2012;126(23):2720-7.
  57. Maisano F, Franzen O, Baldus S, et al. Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. J Am Coll Cardiol. 2013;62(12):1052-1061.
  58. Fan Y, Wan S, Wong RH, Lee AP. Atrial functional mitral regurgitation: mechanisms and surgical implications. Asian Cardiovasc Thorac Annals. 2020;28:421–426.